T. Rowe Price Associates’s Imunon IMNN Stock Holding History

T. Rowe Price Associates’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-485	Closed	-$69K	–	2701
2020 Q3	$69K	Buy	485 +177	+57%	+$44.7K	﹤0.01%	2533
2020 Q2	$224K	Hold	308	–	–	﹤0.01%	2332
2020 Q1	$54K	Hold	308	–	–	﹤0.01%	2451
2019 Q4	$103K	Hold	308	–	–	﹤0.01%	2456
2019 Q3	$93K	Hold	308	–	–	﹤0.01%	2457
2019 Q2	$110K	Hold	308	–	–	﹤0.01%	2467
2019 Q1	$118K	Hold	308	–	–	﹤0.01%	2459
2018 Q4	$85K	Hold	308	–	–	﹤0.01%	2496
2018 Q3	$167K	Hold	308	–	–	﹤0.01%	2487
2018 Q2	$178K	Hold	308	–	–	﹤0.01%	2475
2018 Q1	$135K	Hold	308	–	–	﹤0.01%	2468
2017 Q4	$161K	Buy	+308	New	+$175K	﹤0.01%	2453
2016 Q4	–	Sell	-27	Closed	-$91K	–	2559
2016 Q3	$91K	Hold	27	–	–	﹤0.01%	2457
2016 Q2	$95K	Hold	27	–	–	﹤0.01%	2429
2016 Q1	$109K	Hold	27	–	–	﹤0.01%	2405
2015 Q4	$144K	Hold	27	–	–	﹤0.01%	2364
2015 Q3	$125K	Hold	27	–	–	﹤0.01%	2381
2015 Q2	$176K	Buy	27 +13	+93%	+$92.3K	﹤0.01%	2376
2015 Q1	$100K	Buy	+14	New	+$97.4K	﹤0.01%	2467

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

T. Rowe Price Associates's IMNN Position: Q4 2020 in Review

T. Rowe Price Associates sold out of Imunon (IMNN) in Q4 2020, closing a stake of 485 shares — an estimated $69K sold.

T. Rowe Price Associates first reported a position in IMNN in Q1 2015 and held it in 19 quarters. The position peaked at $224K in Q2 2020. 25 funds tracked by Wall St. Rank hold IMNN as of Q4 2020.

T. Rowe Price Associates reported no remaining Imunon position as of Q4 2020 after selling out during the quarter.
T. Rowe Price Associates sold 485 Imunon shares in Q4 2020, an estimated $69K.
T. Rowe Price Associates first reported a position in Imunon in Q1 2015 and held it in 19 quarters.
T. Rowe Price Associates's Imunon position peaked at $224K in Q2 2020.
25 funds tracked by Wall St. Rank held Imunon as of Q4 2020.

Based on T. Rowe Price Associates's 13F filing for Q4 2020, filed 16 Feb 2021.